GSK to invest $800 million in Pennsylvania biologics manufacturing hub
GSK is investing more than $800 million to expand its Upper Merion Township, Pennsylvania site into a biopharmaceutical manufacturing and research hub. The project will create more than 300 jobs over the next five years and involves demolishing existing buildings to construct new facilities for clinical and commercial biologics production.
4 sourcesJob creation
00